A recent clinical retrospective study demonstrated that the time to progression to CRPC following combined androgen blockade (CAB) therapy was shorter in high-risk PC survivors who had high PSA levels, high Gleason scores (GC), metastasis, etc. at initial diagnosis than non-high-risk PC men13. Here, KLK3 is linked to pachyonychia congenita.